NO874960L - Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff. - Google Patents

Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.

Info

Publication number
NO874960L
NO874960L NO87874960A NO874960A NO874960L NO 874960 L NO874960 L NO 874960L NO 87874960 A NO87874960 A NO 87874960A NO 874960 A NO874960 A NO 874960A NO 874960 L NO874960 L NO 874960L
Authority
NO
Norway
Prior art keywords
active substance
oral administration
liquid dosage
pharmaceutical active
pharmaceutically active
Prior art date
Application number
NO87874960A
Other languages
English (en)
Other versions
NO177177B (no
NO874960D0 (no
NO177177C (no
Inventor
Kjell Johan Mattsson
Alf Gunnar Martin Nicklasson
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of NO874960D0 publication Critical patent/NO874960D0/no
Publication of NO874960L publication Critical patent/NO874960L/no
Publication of NO177177B publication Critical patent/NO177177B/no
Publication of NO177177C publication Critical patent/NO177177C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO874960A 1986-12-22 1987-11-27 Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans NO177177C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Publications (4)

Publication Number Publication Date
NO874960D0 NO874960D0 (no) 1987-11-27
NO874960L true NO874960L (no) 1988-06-23
NO177177B NO177177B (no) 1995-04-24
NO177177C NO177177C (no) 1995-08-02

Family

ID=20366721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874960A NO177177C (no) 1986-12-22 1987-11-27 Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans

Country Status (17)

Country Link
US (1) US5085868A (no)
EP (1) EP0273890B1 (no)
JP (1) JP2778030B2 (no)
AT (1) ATE87471T1 (no)
AU (1) AU609753B2 (no)
CA (1) CA1317883C (no)
DE (1) DE3785167T2 (no)
DK (1) DK668787A (no)
ES (1) ES2039480T3 (no)
FI (1) FI94923C (no)
GR (1) GR3007542T3 (no)
HK (1) HK66396A (no)
IE (1) IE60149B1 (no)
IL (1) IL86607A (no)
NO (1) NO177177C (no)
PH (1) PH25287A (no)
SE (1) SE8605515D0 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
ES2057021T3 (es) * 1988-06-07 1994-10-16 Abbott Lab Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5306507A (en) * 1992-03-26 1994-04-26 Mallinckrodt Specialty Chemicals Company Process and composition containing pamabrom and pyrilamine maleate
US5464625A (en) * 1992-05-08 1995-11-07 Monell Chemical Senses Center Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
US5635200A (en) * 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
CA2150119C (en) * 1992-11-30 2005-03-15 Robert C. Cuca Tastemasked pharmaceutical materials
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
US7799337B2 (en) * 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
AU753476B2 (en) * 1998-11-25 2002-10-17 Cima Labs, Inc. Taste masking rapid release coating system
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
CN1189159C (zh) 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
US7910133B2 (en) 2002-04-09 2011-03-22 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20050037979A1 (en) * 2003-06-05 2005-02-17 Ping Jeffrey H. Tannate compositions and methods of use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) * 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
GB201804621D0 (en) * 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation
US20230312842A1 (en) * 2022-02-08 2023-10-05 Fujifilm Business Innovation Corp. Cellulosic particle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
ES416148A1 (es) * 1972-12-26 1976-06-01 Willian H Rorer Inc Un procedimiento para preparar particulas antiacidas mejo- radas.
JPS5420572B2 (no) * 1973-04-27 1979-07-24
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS6136217A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd 経口投与用持効性製剤
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPS6317821A (ja) * 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
IE59720B1 (en) * 1986-08-11 1994-03-23 Innovata Biomed Ltd Pharmaceutical formulations comprising microcapsules

Also Published As

Publication number Publication date
ATE87471T1 (de) 1993-04-15
GR3007542T3 (no) 1993-08-31
NO177177B (no) 1995-04-24
FI94923B (fi) 1995-08-15
JP2778030B2 (ja) 1998-07-23
NO874960D0 (no) 1987-11-27
ES2039480T3 (es) 1993-10-01
EP0273890B1 (en) 1993-03-31
AU609753B2 (en) 1991-05-09
FI875645A0 (fi) 1987-12-21
IE60149B1 (en) 1994-06-15
EP0273890A1 (en) 1988-07-06
FI94923C (fi) 1995-11-27
US5085868A (en) 1992-02-04
AU8199187A (en) 1988-06-23
DE3785167T2 (de) 1993-07-15
DK668787D0 (da) 1987-12-18
IE873306L (en) 1988-06-22
HK66396A (en) 1996-04-26
FI875645A (fi) 1988-06-23
NO177177C (no) 1995-08-02
PH25287A (en) 1991-04-30
JPS63166838A (ja) 1988-07-11
CA1317883C (en) 1993-05-18
SE8605515D0 (sv) 1986-12-22
IL86607A (en) 1992-03-29
DK668787A (da) 1988-06-23
DE3785167D1 (de) 1993-05-06

Similar Documents

Publication Publication Date Title
NO874960D0 (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
NO883667D0 (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
DK583789A (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
NO177376C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
PT705204E (pt) Saquetas para medicamentos liquidos
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NZ196288A (en) Pharmaceutical active substance administration
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
MY101916A (en) Etoposide oral dosage form.
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
GB8819483D0 (en) Device for administration of pharmacologically active substances
GB8721749D0 (en) Administration of pharmacologically active substances
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
IT8940141A0 (it) Filo medicato per somministrare localmente medicamenti

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003